Literature DB >> 24289924

Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response.

Yong Wu1, Joy C Lin1, Landon G Piluso1, Joseph M Dhahbi1, Selene Bobadilla1, Stephen R Spindler1, Xuan Liu2.   

Abstract

While p53 activation has long been studied, the mechanisms by which its targets genes are restored to their preactivation state are less clear. We report here that TAF1 phosphorylates p53 at Thr55, leading to dissociation of p53 from the p21 promoter and inactivation of transcription late in the DNA damage response. We further show that cellular ATP level might act as a molecular switch for Thr55 phosphorylation on the p21 promoter, indicating that TAF1 is a cellular ATP sensor. Upon DNA damage, cells undergo PARP-1-dependent ATP depletion, which is correlated with reduced TAF1 kinase activity and Thr55 phosphorylation, resulting in p21 activation. As cellular ATP levels recover, TAF1 is able to phosphorylate p53 on Thr55, which leads to dissociation of p53 from the p21 promoter. ChIP-sequencing analysis reveals p53 dissociates from promoters genome wide as cells recover from DNA damage, suggesting the general nature of this mechanism.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24289924      PMCID: PMC3919457          DOI: 10.1016/j.molcel.2013.10.031

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  41 in total

1.  A unified nomenclature for TATA box binding protein (TBP)-associated factors (TAFs) involved in RNA polymerase II transcription.

Authors:  Làszlò Tora
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

2.  Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression.

Authors:  Heng-Hong Li; Andrew G Li; Hilary M Sheppard; Xuan Liu
Journal:  Mol Cell       Date:  2004-03-26       Impact factor: 17.970

3.  Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.

Authors:  H C Ha; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Mammalian TOR: a homeostatic ATP sensor.

Authors:  P B Dennis; A Jaeschke; M Saitoh; B Fowler; S C Kozma; G Thomas
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

5.  A novel method for measurement of submembrane ATP concentration.

Authors:  F M Gribble; G Loussouarn; S J Tucker; C Zhao; C G Nichols; F M Ashcroft
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

Review 6.  Post-translational modification of p53 in tumorigenesis.

Authors:  Ann M Bode; Zigang Dong
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

7.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

Review 9.  The PARP superfamily.

Authors:  Jean-Christophe Amé; Catherine Spenlehauer; Gilbert de Murcia
Journal:  Bioessays       Date:  2004-08       Impact factor: 4.345

10.  PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent.

Authors:  Chantal Ethier; Maxime Tardif; Laura Arul; Guy G Poirier
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more
  27 in total

1.  TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation.

Authors:  Ryo Maeda; Hiroyuki Tamashiro; Kazunori Takano; Hiro Takahashi; Hidefumi Suzuki; Shinta Saito; Waka Kojima; Noritaka Adachi; Kiyoe Ura; Takeshi Endo; Taka-Aki Tamura
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

2.  Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.

Authors:  Fan He; Wade Borcherds; Tanjing Song; Xi Wei; Mousumi Das; Lihong Chen; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

3.  X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.

Authors:  Christine A Vaine; David Shin; Christina Liu; William T Hendriks; Jyotsna Dhakal; Kyle Shin; Nutan Sharma; D Cristopher Bragg
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

4.  Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.

Authors:  Alexander S Krois; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

Review 5.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

6.  Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

Authors:  Gloria S Huang; Alessandro D Santin
Journal:  Cancer       Date:  2017-05-09       Impact factor: 6.860

7.  A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

8.  The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain.

Authors:  Oleg Laptenko; Idit Shiff; Will Freed-Pastor; Andrew Zupnick; Melissa Mattia; Ella Freulich; Inbal Shamir; Noam Kadouri; Tamar Kahan; James Manfredi; Itamar Simon; Carol Prives
Journal:  Mol Cell       Date:  2015-03-19       Impact factor: 17.970

Review 9.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

Review 10.  Transcriptional roles of PARP1 in cancer.

Authors:  Matthew J Schiewer; Karen E Knudsen
Journal:  Mol Cancer Res       Date:  2014-06-10       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.